This SEER analysis shows that rates of active surveillance or watchful waiting for men ages 40+ soared from 16% in 2010 to 60% in 2018 for low risk prostate cancer and from 8% to 22% for favorable intermediate risk disease. | Bashir Al Hussein Al Awamlh JAMA Intern Med 2023
